Dr. Tara Kay Jarreau, MD

Dr. Jarreau practices at Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana.

Dr. Jarreau's NPI, 1871784769, was assigned on August 6, 2007. Dr. Jarreau holds Louisiana license 203021.

Dr. Jarreau's primary practice is Regional Eye Surgery Center - Baton Rouge, at 7777 Hennessey Blvd, Suite 5000, Baton Rouge, LA 70808. The practice phone is (225) 214-6688.

Dr. Jarreau's primary practice is Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana. Dr. Jarreau is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Jarreau to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jarreau practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Jarreau's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Jarreau is licensed in Louisiana.

CMS data shows 5,411 Medicare services from Dr. Jarreau across 23 procedure codes in 2024, for 926 Medicare patients. Medicare paid $133,031 for them.

CMS counts 926 Medicare patients who saw Dr. Jarreau in 2024. The largest group is 65 to 74, with 419 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jarreau's median patient age at 65, with 57% women.

In 2024, Dr. Jarreau wrote 3,336 Medicare Part D claims for 677 patients. 79% of them were for generic drugs. CMS names the drug for 3,117 of them, across 42 drugs with 11 or more claims each, at $717,906 in total drug cost. In 2023, CMS named 4,339 claims across 54 drugs.

Dr. Jarreau accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Jarreau, published from 2011 to 2017. 2011 was the busiest year, with 2. The most frequent topics are Heart Failure, Dietary Supplements and Fatty Acids, Omega-3. Dr. Jarreau has published most often in Congest Heart Fail. Dr. Jarreau's most frequent co-authors are John Hyung-Il Lee, MD, Hector O. Ventura, MD and Krishna Kishore Gaddam, MD.

CMS Open Payments shows 932 general payments to Dr. Jarreau from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. AstraZeneca Pharmaceuticals LP paid the most, $68,875. It also lists 6 research payments totaling $14,000 from 2019 to 2020.